Skip to content
Screener

Net margin at other companies

Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
-37.5%-18.1pp
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-20.3%-9.5pp
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
-418.2%
AbbVie logo
AbbVieABBV
9.8%+3.3pp
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
-174,314.2%-62,763pp
Beam Therapeutics logo
Beam TherapeuticsBEAM
-742.7%

Other financials

Income statement

See full
Revenue$3.3B+12.5%
Gross profit$2.8B+11.2%
Operating income$1.2B+8.3%
Net income$1.1B+6.5%
EPS (diluted)$4.31+8.0%

Balance sheet

See full
Cash & equivalents$7.9B+57.6%
Total debt$2.0B+29.5%
Total equity$20.2B+17.9%
Total assets$27.4B+14.1%

Cash flow

See full
Operating cash flow$1.4B+74.4%
CapEx$133.4M+228%
Free cash flow$1.3B+66.4%

Valuation

See full
Market cap$121.09B-0.2%
Enterprise value$115.22B-2.2%
P/E27.5×
P/S9.6×-1.0×

Profitability

See full
Gross margin86%-0.1pp
Operating margin38%
FCF margin30.4%+20.2pp

Returns & leverage

See full
Return on equity23.5%
Debt / equity0.1×0.0×
Current ratio3.2×+0.7×

Where this comes from

Calculated from Vertex Pharmaceuticals’s reported figures.

Based on trailing twelve months.

The source filing: Vertex Pharmaceuticals’s 8-K, filed August 3, 2026. Open the filing →

Filed
Aug 3, 2026, 4:09 PM EDT
Accession
0000875320-26-000256

FAQ

What is Vertex Pharmaceuticals's net margin?
Vertex Pharmaceuticals (VRTX) reported net margin of 35% in Q2 2026.
What is the long-term trend for Vertex Pharmaceuticals's net margin?
Over 4 years (2020 to 2025), Vertex Pharmaceuticals's net margin has grown at a -6.8% compound annual growth rate (CAGR), from 43.7% to 32.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Vertex Pharmaceuticals's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude